Archy
PrivateLast Round
Series C
Sep 11, 2026
Est. Valuation
$200M
Total Funding Raised
$95M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Archy operates in Healthcare & Life Sciences and is based in San Jose, California. Its latest recorded funding round was a Series C round in September 2026.
Archy is a healthcare technology company that provides a comprehensive cloud-based dental practice management system, integrating patient engagement, payroll, imaging, analytics, and payment processing to streamline operations and enhance productivity for dental practices.
Sector
Healthcare & Life Sciences
Verticals
EHR & EMR, Vertical SaaS, Patient Engagement, Medical Imaging
Business Model
B2B
Customer Profile
Subscription SaaS, Payment Processing Fee
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Archy Comparables
Compare Archy with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Curve Dental | 91% | |
| tab32 | 89% | |
| Oryx Dental Software | 88% |
For institutional investors. Book with your work email.
Archy Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Sep 11, 2026 | ||||
| Series B | Oct 30, 2025 | ||||
| Series A | Oct 24, 2024 | ||||
| Seed | Nov 7, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Archy Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Adapt Ventures | Seed |
| 2.12 Angels | Seed |
| Alven | Series A, Series C, Seed |
| Entrée Capital | Series B, Series C, Series A |
| TCV | Series C, Series B |
| Diagram Collective | Seed |
| CRV | Series B, Series A, Series C, Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 23, 2026
Grew 19% QoQ, from 116 to 138 employees.
- Sep 11, 2026
$50M round led by JMI Equity
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingSep 11, 2026
On Sep 11th '26, Archy receives $50M in Series C funding led by JMI Equity, with participation from TCV, Entrée Capital, Bessemer Venture Partners, CRV, and Alven, to accelerate AI agent development in California.
For institutional investors. Book with your work email.
Archy Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Archy's valuation, stock price, and market status.
Is Archy a public or private company?
Archy is a private company.
What is the current stock price of Archy?
Archy is a private company, so its shares have no public market price. Caplight tracks Archy's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Archy worth (valuation)?
Archy's valuation is estimated at $200.0M based on funding round data.
Can I buy Archy stock?
Archy shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Archy's last funding round?
Archy's most recent funding round was Series C on September 11, 2026.
Who are the main investors in Archy?
Key investors in Archy include Entrée Capital, TCV, CRV, Bessemer Venture Partners, JMI Equity.
Will Archy IPO soon?
No public IPO plans have been announced for Archy.
How can I track Archy secondary market activity?
Caplight tracks bids, offers, and trades in Archy's shares on secondary markets.